<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 250 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page249.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=250">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 250 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 250</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=250"><img src="../thumb/250.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Urinary System - 16.2 / 16.3 / 16.4                                            2020-04 / 213
       flush., vulva pain, water retent./hyponatraem., water intoxicat.,   Indications: Gastr.antacid., urin.alkalinis., crystallur.prevent.dur.  URALYT-U, (Mylan) Takeda [P/S]
       large dos. produc.press.eff.in anaesth./ pts.tak. ganglion or adrenerg.  sulphonamide treatm.  Potassium sod.hydrog.citrate 2,43 g/5 g
       neuron.block./sympathet outflow defects. Nas.admin: nas.congest./  (S0) EFFERV.GRANS. 29/18.3/0379.  Indications: Urine alkalin., dissolut.& prevent.of uric acid stones,
       rhinit./ epistax.& change in nas.mucosa  820059-005: 60 g, R19,77  sympt.treatm.of porphyr.cutanea tarda.
       Special precautions: Observe childr.for fluid overingest./ poss.water   820059-013: 120 g, R33,92  (S0) GRAN. H/18.4/1773. 1 meas.=2,5 g.
       intoxic., when used for diagnost.purpos. limit fluid.intake to &lt; 0,5 L from   Dosage: Take on empty stom.in ½ glass of H2O follow.by addit. H2O.  773948-007: 280 g, R665,45
       1 hr.bef.unt.8 hrs.aft.admin., concom.pressor agents, B/P monit.in heart   Adults: 1-2 medic.meas. (4-8 g) 2-3xdly. Childr: 6-12 yrs: 1 medic.  Dosage: 4 meas./day in div.doses aft.meals. Adjust accord.to urine
       dis./hypertens.pts., limit dos.to prod. desir.physiolog.response, do not ad-  meas. (4 g) 2-3xdly.  pH determ.by indic.paper.
       min.to dehydrat. pts.unt.water balance restor., elderly, condit. charact.by   Contraindications: Sev.ren.dis., metabol.disturb. with alkalos.,   Contraindications: CF, imp.liv./ren.funct., hypernatraem., hyper-
       fluid/elect.imbal., interrupt treatm. at signs of fluid retent./hyponatraem.,   hypocalcaem., hypochlorhydr., concom. urin.tract antisept.requir.  kalaem., alkalos., K-spar. diuret.
       condit. req.concom.diuret.agents, coron.art.insuff. &/ hypertens.CV dis.,   acid urine.  Special precautions: 2-2½ L fluid intake dly., CF, low Na diet.
       cyst.fibros., absorpt.with colds not est., pts.at risk of incr.IC-press., consid.   Side effects: GI disturbs., metabol.alkalos.with excess.admin.in imp.
       sev.bladd.dysfunct.& outlet obstruct.bef. treat. prim.noct.enures., empty   ren.funct., musc. hypertonicity, twitch.& tetany in hypocalcaem. pts.,   URI-ALK, Medchem [P/S]
       bladd.at time of admin., precaut. to avoid hyponatraem., do not use in-  Na overload.& hyperosmolality with excess. dos.  Na-citr. 615 mg, Na-bicarb. 1 362 mg, tartaric acid 860 mg, citr.
       tranas. applicat.when absorpt.may be unreliab./ erratic.  Special precautions: Ren.insuffic., CHF, hypertens., bacteriu-  acid anhydr. 700 mg.
       Drug interactions: TCA’s, SSRI’s, chlorpromazine & carbamazepine   ria not eradicat.  Indications: Gastr.antacid., urin.alkalinis.
       may cause addit.antidiuret.eff., chlorpropamide/ clofibrate/carbamaz-  Drug interactions: Antacids with comprom.ren. funct.may absorb   EFFERV.TABS. 31/18.3/0414.
       epine may prolong the act., poss.water retent./hyponatraem. induct.  dangerous.high amounts of Al.  841986-002: 12, R51,75
       with NSAID’s, glibenclamide may reduc. antidiuret. respons., incr.  Dosage: Admin.2-3xdly.on empty stom.in H2O.
       plasma conc.with loperamide, indomethacin incr.magnit.of respons.  ALKAFIZZ, Cipla Medpro [P/S]  Adults: 1-2 tabs. Childr.6-12 yrs: 1 tab.
       Warnings: Overhydrat.incl.card.fail., avoid over-ingest. fluid in childr.,   Na-citr. 0,613 g, Na-bicarb. 1,716 g, citr.acid anhydr.0,702 g, tartaric   Contraindications: Sev.ren.dis., metabol./ resp. alkalos., hypocal-
       in enures.treatm.limit.fluid intake 1 hr.bef.& 8 hrs.aft.admin., treatm.  acid 0,858 g, liq.gluc.0,34 ml/4 g  caem., hypochlorhydr., concom. urin.tract antisept.requir.acid urine,
       without concom.fluid reduc.poss lead to water retent./ hyponatraem.   Indications: Urin.alkalinis., gastr.antacid.  pts.on Na restrict.diet.
       with/without assoc.effs.incl. convuls.  EFFERV.GRANS, 29/18.3/0378  Side effects: GI disturbs.
       DDAVP, Ferring [P/S]          816256-012: 60 g, R50,86     Special precautions: Ren.insuffic./abnormalit, CHF, hypertens.,
       Desmopressin.                 816256-004: 120 g, R76,41    aldosteron., oed., bact.not eradicat., pept.ulc., monit.ser.electrol.
       Indications: Diagn.of centr.diab.insipid., urin. conc. capac.test.  Dosage: Take on empty stom.in H2O  in ren.dis.
       (S4) INJ. S/8.1/360. 4 µg/ml.  Adults: 1-2 medic.meas. (4-8 g) 2-3xdly..  Drug interactions: Dangerous.high amnts of Al poss.absorb.with
       717754-006: 10x1 ml, R1 115,04  Childr: 6-12 yrs: 1 medic.meas. (4 g) 2-3xdly.  antacids in comprom.ren.funct.
       Dosage: Centr.diab.insipid.diagn: Indiv.dos. Use when intranas.  Contraindications: Sev.ren.dis., metabol. disturb.alkalos., hy-
       admin.unsuit. Norm.dos, IVI. Adults: 1-4 µg 1-2xdly. Childr.over 1
       yr: 0,4-1 µg 1-2xdly. Childr.bel.1 yr: 0,2-0,4 µg 1-2xdly.  pocalcaem., hypochlorhydr., concom.urin.tract antisept.requir.
                                     acid urine.
       Urin.conc.capac.test: Norm.adult dos: IM/SC admin. 4 µg. Childr.  Side effects: GI disturbs., metabol.alkalos.in imp.ren.funct.with ex- 16.4   Urinary antiseptics
       over 12 mnths: 1-2 µg. Und. 12 mnths: 0,4 µg. Use intranas.pre-
       sentat.primarily for childr.  cess.admin., musc. hypertonicity, twitch.& tetany esp.in hypocalcaem.   MACRODANTIN (MDR Listing)
       Side effects: Tachycard., headaches, mild abdom. cramps, N&V, fac.  pts., Na overload. & hyperosmolality & result. oed.with excess.dos.
       flush., vulv.pain, water intoxicat. from overhydrat.  Special precautions: Ren.insuffic., bacteriur. not eradicat., CHF,   DEBLASTON, Takeda [P/S]
       Special precautions: Fluid overload., heart dis., hypertens., cyst.  hypertens.  Pipemidic acid trihydrate (equiv.to pipemidic acid). Sugar-free.
       fibros., sensitiv.test in pts. hypersens. to ADH, large dos.pressor eff.in   Drug interactions: Poss.danger.high amnts of Al absorb.with ant-  Indications: Cystit., urethrit., pyelonephr., ac. prostatit.
       anaesth., pts.tak.ganglion/adrenerg.neur.block.or sympathet.outflow   acids.in imp.ren.funct.  (S4) CAPS. S/18.5/42.
       defects, myocard.ischaem. induc./ exacerb., pregn.  CITRO-SODA, AI Pharm Ltd [P/S]  717770-001: 200 mg, 20, R178,72
       Drug interactions: Indomethac.incr.magnit.of respons., glibencla-  Na-citr. 613 mg, Na-bicarb. 1716 mg, tartaric acid 858 mg, citr.  717770-028: 200 mg, 40, R357,52
       mide may reduc.antidiuret. respons., carbamazepine may prolong act.  acid 702 mg/4 g.  Dosage: 2 caps 2xdly with food for at least 5  days not ex-
       Warnings: Overhydrat., not suit.for infts.und.3 mnths.  Indications: Urin.alkalinis., gastr.antacid., prev.crystallur.dur.sul-  ceed.10 days.
       See also MDR page 315-320.                                 Contraindications: Grow.childr./adolesc., imp. ren.funct., hepat.
                                     phonamide treatm.            dis., pregn.& lactat.
       MINIRIN MELT, Ferring, [P/S] &  (S0) GRANS, [P/S] E1031.   Side effects: GI sympt., headache, dizz., fatig., stomatit., thirst,
       Desmopressin acet.            821837-001: 60 g bottles, R37,54  skin reacts., anaphylax.
       Indications: Centr.diab.insipid., short-treatm.of prim. noct.enuresis   821837-028: 120 g bottles, R55,21  Special precautions: Avoid excess.sunlight expos./UV radiat., con-
       in childr.over 5 yrs. who have norm. ability to conc.urine.  832588-024: 8x4 g sachets, R25,43  sid.benef.-risk ratio in epilep., nalidixic acid cross-resist.
       (S4) SUBLING.TABS, 42/18.2/0346, 0347  832588-008: 30x4 g sachets, R67,90  Drug interactions: Caffeine elimin.half-life may be incr.& clear.decr.,
       722060-001: 120 µg, 30, R696,65  (S0) CRANBERRY GRANS. [P/S] 28/18.3/0372  poss.reduc.theophyll.clear.
       722061-001: 240 µg, 30, R1 394,66  715589-001: 60 g, R37,54
       Dosage: Place und.tong. Discont.if adeq.clinic. eff.not achiev.  715589-002: 120 g, R55,21  MACRODANTIN, Aspen Pharmacare [P/S] &
       wihthin.4 wks.follow.dos titrat,  715590-001:30x4 g sachets, R67,90  Nitrofurantoin
       Centr.diab.insipid: Indiv. Tot.dly.dos.betw.120-720 µg. Adults &   Dosage: Take on empty stom.in ½ glass of water follow.by ad-  Indications: Treatm.& prev.of recur.uncomplicat. low.UTI’s
       childr: Suit.start.dos: 60 µg 3xdly.adjust.accord.to respons. Maint:   dit.water.  (S4) CAPS, G/18.5/160, 161
       Gen.60-120 µg 3xdly.          Adults: 1-2 med.meas. (4-8 g) 3-4xdly.  739839-004: 50 mg, 50, R326,48
       Prim.noct.enures: Init.120 µg at bedt.incr.up to 240 µg if low.dos.not suf-  Long-term ther: 1 med.meas.dly.  739847-004: 100 mg, 50, R627,53
       fic.effect. Treatm.period of up to 4-8 wks. Admin.recomm.dos.only once   Childr: 6-12 yrs: 1 med.meas.(4 g) 2-3xdly.  Dosage: Adults: Ac.UTI: 50-100 mg 4xdly.with meals & at bedt.
       every 24 hrs. Assess need for contin.treatm.by withdr.for at least 1 wk.  Contraindications: Sev.ren.dis., metabol.disturb. alkalos., hypoc-  Prev.recurr: 50-100 mg/day.
       Contraindications: Nephrogen.diabet.insipid., known/suspect.card.  alcaem., hypochlorhydr., Na-restrict. diet, antisept.requir.acid urine.,   Ac.UTI: Childr: 5-7 mg/kg bm/day in 4 div.dos.
       insuffic.& other condits.req. diuret.treatm., mod.to sev.ren.insuffic.,   eff.in pregn.not est.  Prev.recurr: 1 mg/kg/day
       habit.& psychogen. polydipsia, hyponatraem., SIADH, oedemat. states   Side effects: GI disturbs., metabol.alkalos.esp.in pts.with imp.ren.  Contraindications: Anur., oligur., pregn.at term., infts.und.1 mnth
       not assoc.with endogen. vasopress. defic., safety in pregn.not est.,   dysfunct., hypernatraem.& laxat. eff., Na overload & hyperosmolal.  of age, safety in early pregn.not est., G6PD defic., concom.quino-
       Side effects: Hyponatraem., anaphylact.reacts., headache, dizzin, in-
       somn., somnol., asthen., hypertens., N&V, abdom.pain, diarrh., constipat.,   with excess.dos. incr.thirst, hypernatraem., musc.hypertonic., twitch.   lones, ren.impairm.
                                     & tetany in hypocalcaem.
       psych.disords.in childr., bladd.& urethr.sympts., oed., fatig., hypokalaem.,   Side effects: Haemolyt.anaem., GI disturbs., hypersens. reacts., ana-
       paraesthes., vis. impairm., vertigo, palpitat., orthostat.hypotens., dyspn.,   Special precautions: Pept ulcerat., ren.abnorm., liv.cirrh., CHF, hy-  phylax., lupus-like syndr., myalg., arthralg., ac./subac.& chron.pulm.
       dyspeps., flatul., bloat.& distens., sweat., prurit., rash, urticar., musc.  pertens., periph./pulm.oed., pre-eclamps., bact.not eradicat., lactat.,   sensitiv. react., interstit. pulm.fibros.in chron.medicat., hepatotox.,
       spasm, myalg., malaise, chest pain, flu-like illn., weight incr., incr.hepat.   allow 1-2 hrs. aft.tetracycl.admin.& at least aft.ketoconaz. admin.,   bld.dyscras., periph.neuropathy, headache, dizzin., nystagm., drow-
       enzyme, confus.state, allerg.dermat., coma, epistax.in childr.  concur.methenamine not recomm.  sin., sev. polyneuropath.with demyelinat.& degenerat.of sensory &
       Warnings and special precautions: Poss. hyponatraem.with   Drug interactions: Concurr.antacid poss.result in system.alkalos.,   motor nerves, trans.alopec., superinfect. of GUT only.
       assoc.effs.incl.convuls.with excess.water intake, when used for   poss promote developm.of Ca stones & hypernatrem., Al.contain.  Special precautions: Course not to exceed 14 days, separate rep.
       prim.noct. enures.minim.fluid.intake from 1 hr.bef.until 8 hrs. aft.  antacids poss. incr.Al.absorpt., solubil.of ciprofloxacin/ norfloxacin/   courses., asthma, monit.pulm. funct.in elderly & prolong.ther., dis-
       admin., concom.pressor agents, at low dos. food intake may reduc.  oflxacin in urine poss.reduc., salicylat. poss.incr.urin.excret.& decr.  cont.if haemolys. pres., pseudomon.implicat.in superinfects., urine
       intens.& durat.of the antiduret. eff., unknown if enters mothers milk   salicylat.therapeut. eff., tetracycl.absorpt.poss.decr., reduc. ketocona-  col.brown, early report.of periph. neuropathy/condits.predispos.to
       but GI absorpt.unlikely, interrupt treatm.at signs of fluid retent./ hy-  zole absorpt., effectiv.of methenamine poss.reduc.  periph. neuropathy, predisposit.to pulm./hepat./ neurologic. & al-
       ponatraem., treatm.not recomm.in pts. &gt;65 yrs., no stud.perform.in   PROPAN MIST.POT.CIT.SIMPLEX,   lerg.disord., elderly.
       hepat.impairm., hyponatraem. is revers.& in childr.often.occurs in   Drug interactions: Probenec/sulphinpyrazone reduc.excret., Mg
       relat. to changes in dly routines affect.fluid intake &/ perspirat., incr.   AI Pharm Ltd [P/S]  trisilicate reduc.absorpt., antagon. with nalidix.& oxolinic acid, do
                                     Potassium citr.(monohydrate).
       hyponatraem.risk with ser.Na lev. in low.range of norm., sev.bladd.  not admin. with concom.quinolones.
       dysfunct.& outlet obstruct., interrupt.treatm.in illn.charact.by fluid.   Indications: Urin.alkalinizer in inflamm.bladder condits., to prev.  See also MDR page 183.
       &/electrol.imbal., incr.IC press.risk, fluid/ electrol. imbal., concom.  crystallur.dur.sulphonamide treatm.
       meds.known to induc. SIADH, concom. NSAID’s.  (S0) LIQ, H/18.3/1859. 1,25 g/15 ml.  PUROMYLON, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
       Drug interactions: TCA’s/SSRI’s/chlorpromazine/ carbamazepine   805130-004: 100 ml, R3,38  Nalidixic acid.
       & antidiab.of sulfonylurea group may cause addit.antidiuret.eff., car-  805130-012: 200 ml, R6,71  Indications: Suscept.gram neg.organ.UTI.
       bamazepine may prolong the act., NSAID’s poss induc.water retent./  Dosage: Admin in water 3xdly with/immed.aft. meals.  (S4) TABS. K/18.5/247.
       hyponatraem., incr.plasma conc.with loperamide.  Adults: 10ml. Childr. 6-12 yrs: 5 ml.  745685-005: 500 mg, 100,
       See also MDR page 332.        Contraindications: Urin.antisept.which req.acid urine, ren.fail./  Dosage: 4 g dly in 4 div.dos.for at least 7 days. R375,46
                                     hyperkalaem., safety in pregn. & lactat.not est.  Prolong.treatm: 2 g dly. Childr: 55-60 mg/kg bm dly in 2-4 div.doses.
                                     Side effects: Metabol.alkalos.with excess. admin. esp.in pts.with   Contraindications: CNS damage, convuls., imp.ren./hepat funct.,
       16.3   Urinary alkalinizers   imp.ren.funct., GI disturbs, poss. musc.hypertonic., twitch & tetany   infts.und.1 mnth., 1st trimest.pregn.
                                     esp.in hypocalcaem., hyperkalaem with excess.dos.
                                                                  Side effects: GI disturb.& bleed., CNS eff., bld. dyscras., allerg.re-
                                     Special precautions: Ren.insuffic., bact.not eradicat., pts.on K + spar.  acts., musc.weakn., myalg., arthralg.
       ADCO-SODASOL, AI Pharm Ltd [P/S]  diur., adren.cortic.insuff. acidos., aft.tiss.trauma.  Special precautions: Resp.depress., avoid sunlight expos.,
       Na-citr. 0,613 g, Na-bicarb. 1,716 g, citr.acid anhydr. 0,702 g, tar-  Drug interactions: Dangerous.high amounts of Al poss. absorb.  lact.intol.,
       taric acid 0,858 g/4 g.       with.concom.antacids in comprom. ren. funct.  Drug interactions: Nitrofurantoin interfer.with therap.act.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page249.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page245.html">245</a>&nbsp;&nbsp;&nbsp;<a href="page246.html">246</a>&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>&nbsp;&nbsp;&nbsp;<a href="page249.html">249</a>&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>&nbsp;&nbsp;&nbsp;<a href="page251.html">251</a>&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>&nbsp;&nbsp;&nbsp;<a href="page253.html">253</a>&nbsp;&nbsp;&nbsp;<a href="page254.html">254</a>&nbsp;&nbsp;&nbsp;<a href="page255.html">255</a>
             </td>
             <td width="35%"><a href="page251.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page251.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
